Stock listing
OTC:AOLS Aeolus Pharmaceuticals Inc Stock
Follow Aeolus Pharmaceuticals Inc into a list and get an email when it puts out news.
Share price · OTC:AOLS
$0.0001 USD 0.0000 (0.0%)
Close on Nov 19, 2026 · Data provided by Twelve Data
- Day range
- $0.0001 – $0.0001 USDNov 19, 2026
- Market cap
- —Left out: price × shares is far from the company's reported size
- 52-week range
- $0.0001 – $0.0001 USDLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
- Traded on an average day
- $0 USDMedian day 0 shares · 66 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026

Daily closes
Last 3 months, Aug 19, 2026 – Nov 19, 2026 · OTC:AOLS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 |
- Ticker
- OTC:AOLS
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
Latest news
Aeolus Pharmaceuticals Inc on 6ix
- News releases
- 32 in all · newest Mar 23, 2018 · oldest 2015
- Decks
- 2 decks · latest January 2013
Valuation
price Nov 19, 2026
- Enterprise value
- No market cap
- P/E
- No market cap
- EV/sales
- No market cap
- EV/EBITDA
- No market cap
- Price/book
- No market cap
- Gross margin
- No statements on 6ix yet
- Operating margin
- No statements on 6ix yet
- Net margin
- No statements on 6ix yet
- Debt to equity
- No statements on 6ix yet
- Beta vs S&P 500
- 0.00
Team and board
Officers
| Officer | Role |
|---|---|
| John L. McManus | Chief Executive Officer |
| Russell Skibsted | Chief Financial Officer |
| Christopher Stanley | VP, Operations |
| Brian Day | Chief Scientific Officer |
Board
| Director | Role |
|---|---|
| David C. Cavalier | Chairman |
| Amit Kumar | Board Member |
| Chris A. Rallis | Board Member |
| Jeffrey A. Scott | Board Member |
| John M. Clerici | Board Member |
| John M. Farah | Board Member |
| Mitchell D. Kaye | Board Member |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2013) | Investor deck | 31 slides | January 2013 |
| Investor Presentation (November 2004) | Investor deck | 34 slides | Nov 16, 2004 |
Cap table
Built by 6ix from Aeolus Pharmaceuticals Inc’s releases
- Common shares
- 152,085,825
- Fully diluted
- 152,085,825
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 152,085,825 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 152,085,825 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Russell Skibsted Other companies: Processa Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Jul 16, 2024); Alimera Sciences Inc (Chief Financial Officer & SVP · Jan 9, 2023 – Nov 21, 2023 · Past); Rockwell Medical, Inc. (See Remarks · Sep 15, 2020 – Sep 9, 2022 · Past); Serina Therapeutics, Inc. (Chief Financial Officer · Nov 27, 2018 – Dec 31, 2018 · Past); Insight Molecular Diagnostics Inc. (Chief Financial Officer · Dec 30, 2015 – Dec 30, 2015 · Past); Lineage Cell Therapeutics, Inc. (Chief Financial Officer · Nov 16, 2015 – Dec 18, 2018 · Past) | Chief Financial Officer · Since at least May 23, 2012 |
| Chris A. Rallis Other companies: Fennec Pharmaceuticals Inc. (Director · Since at least Sep 11, 2017); Tenax Therapeutics, Inc. (Director · Dec 16, 2011 – Jun 15, 2020 · Past) | Board Member · Since at least Sep 12, 2006 |
| Amit Kumar Other companies: Anixa Biosciences, Inc. (Chief Executive Officer, Director · Since at least May 8, 2018) | Board Member · Since at least Nov 14, 2026 |
| David C. Cavalier Other companies: Anixa Biosciences, Inc. (Director · Sep 27, 2018 – Aug 13, 2020 · Past) | Chairman · Since at least Jul 27, 2007 |
| Joseph J Krivulka Other companies: Nektar Therapeutics (Director · Sep 19, 2013 – Sep 19, 2017 · Past) | Director · May 8, 2013 – May 8, 2013 · Past |
| Brian Day | Chief Scientific Officer · Since at least Nov 14, 2026 |
| Christopher Stanley | VP, Operations · Since at least Nov 14, 2026 |
| Jeffrey A. Scott | Board Member · Since at least Nov 14, 2026 |
| John L. McManus | Chief Executive Officer · Since at least Dec 30, 2005 |
| John M. Clerici | Board Member · Since at least Nov 14, 2026 |
All 12 people
| Person | Seat |
|---|---|
| John M. Farah | Board Member · Since at least Nov 14, 2026 |
| Mitchell D. Kaye | Board Member · Since at least Nov 14, 2026 |
Log in to ask 6ix AI your own questions about Aeolus Pharmaceuticals Inc.